14-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis

The 14-3-3<b><i>η</i></b> (eta) protein was evaluated as a biomarker in a cohort of patients with juvenile idiopathic arthritis (JIA), as well as disease- and healthy-controls, to determine its potential clinical utility. In this case-control study, levels of 14-3-3<b>&...

Full description

Bibliographic Details
Main Authors: Austin Dalrymple, Paul Tuttle, Lance Feller, Olga Zhukov, Robert Lagier, Joanna Popov, Stanley Naides, Terry Moore
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Pediatric Reports
Subjects:
Online Access:https://www.mdpi.com/2036-7503/13/1/8
_version_ 1827598011935490048
author Austin Dalrymple
Paul Tuttle
Lance Feller
Olga Zhukov
Robert Lagier
Joanna Popov
Stanley Naides
Terry Moore
author_facet Austin Dalrymple
Paul Tuttle
Lance Feller
Olga Zhukov
Robert Lagier
Joanna Popov
Stanley Naides
Terry Moore
author_sort Austin Dalrymple
collection DOAJ
description The 14-3-3<b><i>η</i></b> (eta) protein was evaluated as a biomarker in a cohort of patients with juvenile idiopathic arthritis (JIA), as well as disease- and healthy-controls, to determine its potential clinical utility. In this case-control study, levels of 14-3-3<b><i>η</i></b> protein were evaluated in archival specimens from patients with JIA, systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA), as well as healthy pediatric controls. Just over 200 patients were evaluated, using specimens banked between 1990 and 2011. Comparisons were made to complete blood cell count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, and anti-nuclear antibody (ANA) positivity. 14-3-3<b><i>η</i></b> at levels 0.2 ng/mL or higher was considered positive. Fisher’s exact tests, odds ratios, 95% confidence intervals, and p-values were reported. 14-3-3<b><i>η</i></b> positivity was seen in all included JIA subtypes. The rate of positivity was the highest in RF-positive (pos) polyarticular JIA. In the disease and healthy controls, lower rates of positivity were observed. The frequency of 14-3-3<b><i>η</i></b> positivity among RF-positive and RF-negative (neg) polyarticular JIA patients, especially at values ≥0.5 ng/mL (associated with poor outcomes in adults), was also highest. Several JIA patients with 14-3-3<b><i>η</i></b> positivity developed RF and anti-CCP positivity later in their disease. Significant levels of 14-3-3<b><i>η</i></b> can be found in approximately 30% of RF-pos and RF-neg patients with polyarticular JIA. This protein may represent a new biomarker for polyarticular JIA, particularly RF-neg polyarticular JIA.
first_indexed 2024-03-09T03:43:31Z
format Article
id doaj.art-7e28316fff9e4303b835c18b26c8b4fb
institution Directory Open Access Journal
issn 2036-7503
language English
last_indexed 2024-03-09T03:43:31Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Pediatric Reports
spelling doaj.art-7e28316fff9e4303b835c18b26c8b4fb2023-12-03T14:37:28ZengMDPI AGPediatric Reports2036-75032021-01-01131657110.3390/pediatric1301000814-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic ArthritisAustin Dalrymple0Paul Tuttle1Lance Feller2Olga Zhukov3Robert Lagier4Joanna Popov5Stanley Naides6Terry Moore7Division of Adult & Pediatric Rheumatology, Saint Louis University School of Medicine & SSM Health Cardinal Glennon Children’s Hospital, Saint Louis, MO 63104, USADivision of Adult & Pediatric Rheumatology, Saint Louis University School of Medicine & SSM Health Cardinal Glennon Children’s Hospital, Saint Louis, MO 63104, USADivision of Adult & Pediatric Rheumatology, Saint Louis University School of Medicine & SSM Health Cardinal Glennon Children’s Hospital, Saint Louis, MO 63104, USAQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92675, USAQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92675, USAQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92675, USAQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92675, USADivision of Adult & Pediatric Rheumatology, Saint Louis University School of Medicine & SSM Health Cardinal Glennon Children’s Hospital, Saint Louis, MO 63104, USAThe 14-3-3<b><i>η</i></b> (eta) protein was evaluated as a biomarker in a cohort of patients with juvenile idiopathic arthritis (JIA), as well as disease- and healthy-controls, to determine its potential clinical utility. In this case-control study, levels of 14-3-3<b><i>η</i></b> protein were evaluated in archival specimens from patients with JIA, systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA), as well as healthy pediatric controls. Just over 200 patients were evaluated, using specimens banked between 1990 and 2011. Comparisons were made to complete blood cell count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, and anti-nuclear antibody (ANA) positivity. 14-3-3<b><i>η</i></b> at levels 0.2 ng/mL or higher was considered positive. Fisher’s exact tests, odds ratios, 95% confidence intervals, and p-values were reported. 14-3-3<b><i>η</i></b> positivity was seen in all included JIA subtypes. The rate of positivity was the highest in RF-positive (pos) polyarticular JIA. In the disease and healthy controls, lower rates of positivity were observed. The frequency of 14-3-3<b><i>η</i></b> positivity among RF-positive and RF-negative (neg) polyarticular JIA patients, especially at values ≥0.5 ng/mL (associated with poor outcomes in adults), was also highest. Several JIA patients with 14-3-3<b><i>η</i></b> positivity developed RF and anti-CCP positivity later in their disease. Significant levels of 14-3-3<b><i>η</i></b> can be found in approximately 30% of RF-pos and RF-neg patients with polyarticular JIA. This protein may represent a new biomarker for polyarticular JIA, particularly RF-neg polyarticular JIA.https://www.mdpi.com/2036-7503/13/1/8juvenile idiopathic arthritis14-3-3 proteinsbiomarkers
spellingShingle Austin Dalrymple
Paul Tuttle
Lance Feller
Olga Zhukov
Robert Lagier
Joanna Popov
Stanley Naides
Terry Moore
14-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
Pediatric Reports
juvenile idiopathic arthritis
14-3-3 proteins
biomarkers
title 14-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
title_full 14-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
title_fullStr 14-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
title_full_unstemmed 14-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
title_short 14-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
title_sort 14 3 3 i η i protein as a potential biomarker in juvenile idiopathic arthritis
topic juvenile idiopathic arthritis
14-3-3 proteins
biomarkers
url https://www.mdpi.com/2036-7503/13/1/8
work_keys_str_mv AT austindalrymple 1433iēiproteinasapotentialbiomarkerinjuvenileidiopathicarthritis
AT paultuttle 1433iēiproteinasapotentialbiomarkerinjuvenileidiopathicarthritis
AT lancefeller 1433iēiproteinasapotentialbiomarkerinjuvenileidiopathicarthritis
AT olgazhukov 1433iēiproteinasapotentialbiomarkerinjuvenileidiopathicarthritis
AT robertlagier 1433iēiproteinasapotentialbiomarkerinjuvenileidiopathicarthritis
AT joannapopov 1433iēiproteinasapotentialbiomarkerinjuvenileidiopathicarthritis
AT stanleynaides 1433iēiproteinasapotentialbiomarkerinjuvenileidiopathicarthritis
AT terrymoore 1433iēiproteinasapotentialbiomarkerinjuvenileidiopathicarthritis